Keyphrases
Sorafenib
100%
Primary Biliary Cirrhosis
100%
Sorafenib Treatment
100%
Hepatopulmonary Syndrome
100%
Vascular Endothelial Growth Factor
50%
Common Bile Duct Ligation
50%
Angiogenesis
37%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
37%
Plasma Vascular Endothelial Growth Factor
25%
Intrapulmonary Shunting
25%
Quantitative PCR
12%
Beneficial Effects
12%
Protein Expression
12%
Immunohistochemical Staining
12%
Lung
12%
Experimental Animal Models
12%
Liver
12%
Factor Level
12%
Western Blot Analysis
12%
Distilled Water
12%
Surgical Procedures
12%
Chronic Liver Disease
12%
Histopathological Examination
12%
Oxygen Desaturation
12%
Anti-angiogenesis
12%
Blood Gas Analysis
12%
Treatment Regimen
12%
Water Control
12%
Liver Biochemistry
12%
Antiangiogenesis Therapy
12%
Pulmonary Vascular
12%
Systemic-to-pulmonary Shunt
12%
Akt Protein
12%
Pulmonary Vasodilation
12%
Medicine and Dentistry
Sorafenib
100%
Biliary Cirrhosis
100%
Hepatopulmonary Syndrome
100%
Vasculotropin
60%
Bile Duct Ligation
40%
Common Bile Duct
40%
Angiogenesis
30%
Vasculotropin Receptor 2
30%
Shunting
20%
Hemodynamic
10%
Western Blot
10%
Histopathology
10%
Protein Expression
10%
Real Time Polymerase Chain Reaction
10%
Surgical Technique
10%
Body Weight
10%
Oxygen Desaturation
10%
Chronic Liver Disease
10%
Blood Gas Analysis
10%
Vasodilatation
10%
Protein Kinase B
10%
Pulmonary Shunt
10%
Distilled Water
10%
Antiangiogenic Therapy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Sorafenib
100%
Hepatopulmonary Syndrome
100%
Biliary Cirrhosis
100%
Vasculotropin
60%
Vasculotropin Receptor 2
30%
Western Blot
10%
Experimental Animal
10%
Protein Kinase B
10%
Chronic Liver Disease
10%
Distilled Water
10%
Antiangiogenic Therapy
10%
Immunology and Microbiology
Sorafenib
100%
Vasculotropin
60%
Common Bile Duct
40%
Angiogenesis
30%
Kinase Insert Domain Receptor
30%
Blood Plasma
20%
Hemodynamic
10%
Western Blot
10%
Protein Expression
10%
Real Time Polymerase Chain Reaction
10%
Experimental Animal
10%
Vasodilatation
10%
Body Weight
10%
Antiangiogenic Activity
10%
Blood Gas
10%
Oxygen Desaturation
10%
Biochemistry, Genetics and Molecular Biology
Sorafenib
100%
Vascular Endothelial Growth Factor
60%
Angiogenesis
30%
Kinase Insert Domain Receptor
30%
Hemodynamic
10%
Messenger RNA
10%
Western Blot
10%
Real-Time Polymerase Chain Reaction
10%
Protein Expression
10%
Animal Model
10%
Protein Kinase B
10%
Body Weight
10%
Oxygen Desaturation
10%
Antiangiogenic Activity
10%
Vasodilatation
10%
Experimental Animal
10%
Blood Gas
10%
Liver Biochemistry
10%